$ADCT SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 7, 2026, by and between ADC Therapeutics SA, a société anonyme domiciled in Epalinges, Canton of Vaud, Switzerland, and organized under the laws of Switzerland ...
14 Aug 2026	SCHEDULE 13G
13 Aug 2026	FORM S-8
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
27 Jul 2026	SCHEDULE 13G
02 Jul 2026	Form 4: Zaki Mohamed, Chief Medical Officer Received 213,900 shares as a grant or award
02 Jul 2026	Form 4: Graham Peter J, Chief Legal Officer Received 221,100 shares as a grant or award
02 Jul 2026	Form 4: Carmona Jose, Chief Financial Officer Received 203,700 shares as a grant or award
02 Jul 2026	Form 4: Mallik Ameet, Director Received 675,000 shares as a grant or award
02 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
24 Jun 2026	8-K: Regulation FD Disclosure; Other Events
03 Jun 2026	Form 4: Azelby Robert, Director Received 45,000 shares as a grant or award · Gave up 12,600 shares to cover exercise price or tax ($38.8K)
03 Jun 2026	Form 4: Squarer Ron, Director Received 45,000 shares as a grant or award · Gave up 15,196 shares to cover exercise price or tax ($46.8K)
03 Jun 2026	Form 4: Sandor Victor, Director Received 45,000 shares as a grant or award · Gave up 12,600 shares to cover exercise price or tax ($38.8K)
03 Jun 2026	Form 4: Monges Viviane, Director Received 45,000 shares as a grant or award · Gave up 2,596 shares to cover exercise price or tax ($8K)
03 Jun 2026	Form 4: Hug Peter, Director Received 45,000 shares as a grant or award · Gave up 2,156 shares to cover exercise price or tax ($6.64K)
03 Jun 2026	Form 4: Bizzari Jean-pierre, Director Received 45,000 shares as a grant or award · Gave up 12,600 shares to cover exercise price or tax ($38.8K)
03 Jun 2026	Form 4: Coughlin Timothy, Director Received 45,000 shares as a grant or award · Gave up 12,600 shares to cover exercise price or tax ($38.8K)
03 Jun 2026	8-K: Regulation FD Disclosure; Other Events

Comments